Our Management Team

Andrew Shelling

Andrew Shelling

Professor Andrew Shelling is Associate Dean (Research) at the Faculty of Medical and Health Sciences, and also head of the Medical Genetics Research Group. His research is primarily interested in understanding the molecular changes that occur during the development of genetic disorders, focusing on breast and ovarian cancer, and reproductive disorders.

Andrew began at Otago University with a degree in Physical Education and PhD in Biochemistry. He spent three years in Oxford, UK, as a Nuffield Medical Fellow, studying the genetics of ovarian cancer, before being appointed to Auckland University as a Lecturer in 1996, eventually becoming Professor in 2015.

Andrew has served as Deputy Head of Department of Obstetrics and Gynaecology (2001-2013), President of the New Zealand branch of the Human Genetics Society of Australasia (2002-2004), Deputy-Chairperson of the Advisory Committee for Assisted Reproductive Technologies (2006-2012), Director of the Bachelor of Medical Sciences Honours programme (2008-2016), Associate Dean (PBRF) (2015-2018), Associate Editor for the Human Reproduction journal (2004-2013) and Human Reproduction Update (2021-). He is currently Associate Dean (Research) (2013-), a board member of Breast Cancer Cure, Chair of the Gynaecological Oncology Special Interest Group of the New Zealand Society of Oncology, and is currently acting co-director of the Centre for Cancer Research.

Megan Putterill

Megan Putterill

Megan is the Strategic Development Manager for Faculty of Medical and Health Sciences (FMHS).

Her key responsibility is to manage the relationship the University has with the health sector primarily focussed on DHBs in the Northern Region This is embodied by the Auckland Academic Health Alliance (AAHA) partnership which is underpinned by a core set of principles to encourage our institutions to work within a framework of inter-institutional collaboration with a focus on research, strengthening, teaching and education (workforce development) and service.

One of the key initiatives of the AAHA is the establishment of a University/DHB Integrated Cancer Centre. This work is ongoing and forms a significant cornerstone of Megan’s existing role.

 

Peter Browett

Peter Browett

Peter is a consultant haematologist at Auckland City Hospital and Professor of Pathology in the Department of Molecular Medicine and Pathology, Faculty of Medical and Health Sciences, University of Auckland. He is a graduate of the University of Otago Medical School, and after postgraduate training in clinical and laboratory haematology in Auckland, he was a Wellcome – HRC research fellow in the Department of Haematology, Royal Free Hospital School of Medicine, London. Peter is involved in several co-operative group and investigator initiated studies in blood disorders and stem cell transplantation. He is co-director of the Leukaemia and Blood Cancer Research Unit, with interests in blood cancer genomics, biomarkers in leukaemia, and the monitoring of measurable residual disease. Peter is clinical director of the Auckland Regional Tissue Bank, and Grafton Clinical Genomics.

George Laking

George Laking

George grew up in Wellington and studied medicine in Dunedin and Wellington.  He completed his postgraduate work in Britain where he wrote his MD on tumour perfusion and his PhD on the economics of diagnosis.  Since 2007 he has worked as a Medical Oncologist in Auckland, with current focus areas of gastrointestinal cancer, sarcoma, and adolescent and young adult oncology.

Alongside his hospital work, George is active in Policy and Advocacy at the Royal Australasian College of Physicians (topics including climate change, medical assistance in dying, electronic nicotine delivery systems, and Indigenous health.  At the University of Auckland George is involved in clinical teaching, and collaborates in research with Prof Mark McKeage (Clinical Pharmacology) and Prof Chris Bullen (National Institute for Health Innovation).  He is a former member of PHARMAC’s Pharmacology and Therapeutics Advisory Committee (PTAC).

George’s iwi affiliation is Te Whakatōhea, he is involved in Māori Health as a past Chair of Te ORA (the Māori Medical Practitioners’ Association), as current Chair of the Māori Health Committee of the RACP, and a board member of Hei Ahuru Mowai Maori Cancer Leadership Aotearoa.

Leesa Russell

Leesa Russell

Mrs Leesa Russell is Project Manager for the Centre for Cancer Research at University of Auckland. Most recently she has held roles in Planning Funding and Outcomes, at various Auckland DHBs and regionally: as Programme Manager for Metro Auckland Data Sharing and Lead for Regional Data Governance redesign, Business Manager for Planning, Funding and Outcomes at Waitemata and Auckland DHBs and Project Manager of System Level Measures, a Primary Care population health focused quality improvement programme. She has an interest in ethics which began with the role of Ethics Coordinator at the Health Research Council, and continued with her close relationship with ECART during her time at Fertility Associates. Shortly after this she was appointed to HDEC Northern B (2015) and was reappointed for a further 3 years in 2021. She sat as Chair of the University of Auckland Human Participants Ethics Committee B for two years (2019-21). She has previously worked as a Business Manager in Primary Care and has experience working in clinical quality, improvement and audit related roles, including Quality Lead at Waitemata DHB and Clinical Audit Manager at St John, Process Manager and Extended Storage Co-ordinator at Fertility Associates, and (quality improvement) Data Evaluator at Counties Manukau Health. In her early career she worked in cardiovascular and respiratory clinical research and was a Research Fellow in Neuropsychology. She completed a Post Graduate Diploma in Quality Systems at Massey in 2019 and has a Masters and a Bachelor’s degree in (healthcare related) Sociology from the University of Auckland.